| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $1.29 (Miss by $-0.08) |
| EPS GAAP Actual | $1.29 (Miss by $-0.08) |
| Revenue Actual | $1.55963B |
| Revenue Surprise | Beat by $1559.63M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 8.58 | 13.31 | 8.2022 | 8.91219 | 1 |
| Dec 2026 | 0 | INF | 0 | 0 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.29 | 1.29 | 1.55963B | -5.75% | 1559.63M |
| FQ2 2025 (Jun 2025) | 1.7 | 1.7 | 1.83537B | -3.63% | 1835.37M |
| FQ1 2025 (Mar 2025) | 1.3 | 1.3 | 1.59552B | -2.72% | 1595.52M |
| FQ4 2024 (Dec 2024) | 1.12 | 1.12 | 1.462B | -4.26% | 1462M |
| FQ3 2024 (Sep 2024) | 1.64 | 1.64 | 1.64938B | -10.81% | 1649.38M |
| FQ2 2024 (Jun 2024) | 2.05 | 2.05 | 1.90196B | -7.46% | 1901.96M |
| FQ1 2024 (Mar 2024) | 1.96 | 1.96 | 1.63897B | 100% | 1638.97M |
| FQ4 2023 (Dec 2023) | 1.62 | 1.62 | 1.52435B | -25.54% | 1524.35M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.42588 | -- | 1.39888 | 1.45405 | 1 |
| FQ3 2027 (Sep 2027) | 2.2649 | -- | 2.21186 | 2.3186 | 1 |
| FQ2 2027 (Jun 2027) | 2.4568 | -- | 2.39927 | 2.51505 | 1 |
| FQ1 2027 (Mar 2027) | 1.8689 | -- | 1.82513 | 1.91321 | 1 |
| FQ4 2026 (Dec 2026) | 1.685 | -- | 1.58714 | 1.76502 | 1 |
| FQ3 2026 (Sep 2026) | 2.09443 | 38.41 | 1.95349 | 2.17855 | 1 |
| FQ2 2026 (Jun 2026) | 2.429 | 30.01 | 2.26948 | 2.53606 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.56B | -- | 1.54B | 1.58B | 2 |
| FQ3 2027 (Sep 2027) | 1.7B | -- | 1.67B | 1.73B | 1 |
| FQ2 2027 (Jun 2027) | 1.95B | -- | 1.92B | 1.99B | 1 |
| FQ1 2027 (Mar 2027) | 1.69B | -- | 1.66B | 1.72B | 1 |
| FQ4 2026 (Dec 2026) | 1.56B | -- | 1.49B | 1.62B | 1 |
| FQ3 2026 (Sep 2026) | 1.86B | 15.93 | 1.76B | 1.91B | 1 |
| FQ2 2026 (Jun 2026) | 2.36B | 22.36 | 2.24B | 2.44B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.29 | 1.29 | 100% | |
| FQ2 2025 (Jun 2025) | 1.7 | 1.7 | 100% | |
| FQ1 2025 (Mar 2025) | 1.3 | 1.3 | 100% | |
| FQ4 2024 (Dec 2024) | 1.12 | 1.12 | 100% | |
| FQ3 2024 (Sep 2024) | 1.64 | 1.64 | 100% | |
| FQ2 2024 (Jun 2024) | 2.05 | 2.05 | 100% | |
| FQ1 2024 (Mar 2024) | 1.96 | 1.96 | 100% | |
| FQ4 2023 (Dec 2023) | 1.62 | 1.62 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.56B | $1559.63M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.84B | $1835.37M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.6B | $1595.52M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.46B | $1462M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.65B | $1649.38M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.9B | $1901.96M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.64B | $1638.97M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.52B | $1524.35M | 100% |